Elagolix Cuts Heavy Menstrual Bleeding in Women With Fibroids
THURSDAY, Jan. 23, 2020 -- For women with uterine fibroids, elagolix with add-back hormonal therapy is associated with a reduction in heavy menstrual bleeding compared with placebo, according to a study published in the Jan. 23 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 23, 2020 Category: Pharmaceuticals Source Type: news
DNA changes in breast cancer cells linked to hormone resistance
DNA changes in a common type of breast cancer cell may be linked to hormone therapy resistance, according to a study published inNature Communications.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 17, 2020 Category: Endocrinology Source Type: news
Prostate Cancer Treatment: Hormonal Therapy
Title: Prostate Cancer Treatment: Hormonal TherapyCategory: Diseases and ConditionsCreated: 1/9/2020 12:00:00 AMLast Editorial Review: 1/9/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 9, 2020 Category: Cancer & Oncology Source Type: news
Gen X Women Get Less Sleep Than Any Other Generation. What ’s Keeping Them Up?
In the middle of the night, I wake up feeling warm. I open the window and pull my hair back into a ponytail and drink some water. Then I glance at my phone, delete a few things, and see some spam. I hit unsubscribe and go back to bed. Then I lie there thinking, What if by opening that spam email I got myself hacked? What if I just sent everyone in my contact list a Burger King ad at two in the morning?
Now wide awake, I move on to other concerns: my parents’ health, my stepson’s college tuition, pending deadlines. Hours roll by. I tackle real-life math problems: how many weeks I have before getting my next free...
Source: TIME: Health - January 6, 2020 Category: Consumer Health News Authors: Ada Calhoun Tags: Uncategorized Gen X healthy sleep insomnia Source Type: news
Symptom Burden in Older Breast Cancer Survivors May Be Associated with Lower Well-being
Breast cancer survivors who underwent chemotherapy or hormone therapy were found to be more likely to have a higher symptom burden and lower overall sense of well-being than noncancer counterparts. (Source: CancerNetwork)
Source: CancerNetwork - January 6, 2020 Category: Cancer & Oncology Authors: Kevin Wright Source Type: news
Losing Weight May Reduce Your Risk of Breast Cancer
Excess body weight is an established risk factor for breast cancer. Research suggests that’s because too much body fat can elevate levels of sex hormones like estrogen, especially among postmenopausal women. But despite knowing there is a correlation between extra weight and breast cancer, it’s been difficult to study how losing that weight could affect an individual woman’s chance of developing cancer.
Now, a new paper published in the Journal of the National Cancer Institute provides encouraging evidence that, for women 50 and older, virtually any amount of sustained weight loss translates to a reductio...
Source: TIME: Health - December 17, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer embargoed study Source Type: news
Estrogen hormone therapy may reduce breast cancer risk
A study presented at San Antonio Breast Cancer Symposium suggests that estrogen only hormone therapy for postmenopausal women may reduce the risk of breast cancer, whereas estrogen plus progestin hormone therapy may increase risks.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 17, 2019 Category: Endocrinology Source Type: news
New Data on Menopausal Hormone Therapy
'Remarkable' New Data on Menopausal Hormone Therapy (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 16, 2019 Category: General Medicine Source Type: news
' Remarkable' New Data on Menopausal Hormone Therapy'Remarkable' New Data on Menopausal Hormone Therapy
Estrogen alone and estrogen/progestin have opposite effects on breast cancer risk; adding progestin may lead to a lifetime of increased risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New Study Shakes Up Thinking on Hormone Replacement Therapy
FRIDAY, Dec. 13, 2019 -- The ongoing debate about postmenopausal hormone therapy and breast cancer risk may have turned even more muddy: A large, new study suggests that two different types of hormone therapy have opposite effects on women ' s... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 13, 2019 Category: General Medicine Source Type: news
Targeted therapy drug helps women with aggressive breast cancer live longer
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy significantly improves overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common types of the disease.The findings also show the combination treatment is beneficial at the time of recurrence and should become a first-line option in postmenopausal women with HR+/HER2- advanced breast cancer.The study was published today in the New England Journal of Medicine and presented earlier this year at the European Society for Medical Oncology Congress in...
Source: UCLA Newsroom: Health Sciences - December 11, 2019 Category: Universities & Medical Training Source Type: news
Exercise may help reduce side effects of prostate hormone therapy
Short-term exercise may help reduce the adverse side effects of hormone therapy for patients with prostate cancer, according to a study published in theBritish Journal of Urology International (BJUI).Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 11, 2019 Category: Endocrinology Source Type: news
Reducing the side-effects of prostate hormone therapy with exercise
(University of East Anglia) A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research.The trial aimed to reduce the adverse side-effects of hormone therapy such as weight gain and an increased risk of heart problems. The results show that a three month programme of aerobic and resistance training intervention prevented adverse changes in cardiopulmonary fitness and fatigue (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 9, 2019 Category: Cancer & Oncology Source Type: news
Duke research could advance treatments for prostate cancer
A breakthrough coming out of Duke University has the potential to treat prostate cancer cells that have become impervious to hormone therapy – presenting a wealth of potential therapeutic benefits as researchers press forward. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2019 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news
Duke research could advance treatments for prostate cancer
A breakthrough coming out of Duke University has the potential to treat prostate cancer cells that have become impervious to hormone therapy – presenting a wealth of potential therapeutic benefits as researchers press forward. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 6, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news
